Russian HIV vaccine in clinical trials; Medicago invests $4 million in Quebec;

> An HIV vaccine has completed its first clinical trial in Russia, at the State Research Center for Virology and Biotechnology (Vektor). Article

> Biotech vaccine company Medicago is planning to invest $4 million to enhance the capacity of its pilot production facility in Quebec City. Press release

> DCPrime has received orphan drug designation for its therapeutic cell-based cancer vaccine in development for the treatment of acute myeloid leukemia. Press release

> The Institute of Human Virology, Nigeria predicts an HIV vaccine within the next 5 years. News

> Soligenix's proprietary vaccine thermostabilization technology has passed through its preclinical proof-of-concept studies and can keep vaccine formulations stable without refrigeration. Press release

> The prostate cancer vaccine Provenge could be useful in early-stage cancer, according to a study at UCSF. Article

> The UN is backing a mass yellow fever vaccination campaign in northern Cameroon following an outbreak of deaths from the disease. News

> Pediatricians recommend a 'cocoon' strategy--vaccinating the whole family to protect babies. Item

> Vaccines do not lead to Guillain-Barré syndrome. Story

And Finally... The NIH is looking to fund the preclinical development of technologies to improve vaccine effectiveness and/or simplify vaccine delivery. Funding opportunity announcement

Suggested Articles

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Sanofi's cost cuts are adding up, execs said in an update Wednesday. The company has trimmed nearly €1 billion in annual expenses so far in 2020.

Shingrix sales in the second quarter plummeted by half from first-quarter levels, and recovery of vaccination rates remains slow amid the pandemic.